Problem
Recommend one FDA-approved drug, one off-label drug, and one nonpharmacological intervention for treating major depressive disorder in children and adolescents. Explain the risk assessment you would use to inform your treatment decision making. What are the risks and benefits of the FDA-approved medicine? What are the risks and benefits of the off-label drug? Then, explain whether clinical practice guidelines exist for this disorder and, if so, use them to justify your recommendations. If not, explain what information you would need to take into consideration.